Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.

Hair PS, Enos AI, Krishna NK, Cunnion KM.

Front Immunol. 2018 Mar 26;9:558. doi: 10.3389/fimmu.2018.00558. eCollection 2018.

2.

Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT).

Gregory Rivera M, Hair PS, Cunnion KM, Krishna NK.

PLoS One. 2018 Mar 2;13(3):e0193931. doi: 10.1371/journal.pone.0193931. eCollection 2018.

3.

Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin.

Hair PS, Cunnion KM, Krishna NK.

Int J Pept. 2017;2017:9454583. doi: 10.1155/2017/9454583. Epub 2017 Sep 10.

4.

Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.

Hair PS, Sass LA, Vazifedan T, Shah TA, Krishna NK, Cunnion KM.

PLoS One. 2017 Mar 9;12(3):e0173257. doi: 10.1371/journal.pone.0173257. eCollection 2017.

5.

Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).

Hair PS, Sass LA, Krishna NK, Cunnion KM.

PLoS One. 2017 Jan 30;12(1):e0170203. doi: 10.1371/journal.pone.0170203. eCollection 2017.

6.

Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds.

Cunnion KM, Krishna NK, Pallera HK, Pineros-Fernandez A, Rivera MG, Hair PS, Lassiter BP, Huyck R, Clements MA, Hood AF, Rodeheaver GT, Cottler PS, Nadler JL, Dobrian AD.

PLoS One. 2017 Jan 20;12(1):e0170500. doi: 10.1371/journal.pone.0170500. eCollection 2017.

7.

Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.

Shah TA, Nejad JE, Pallera HK, Lattanzio FA, Farhat R, Kumar PS, Hair PS, Bass WT, Krishna NK.

Pediatr Res. 2017 Apr;81(4):654-662. doi: 10.1038/pr.2016.271. Epub 2016 Dec 21.

PMID:
28002390
8.

Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.

Cunnion KM, Hair PS, Krishna NK, Sass MA, Enos CW, Whitley PH, Maes LY, Goldberg CL.

Transfusion. 2017 Mar;57(3):517-524. doi: 10.1111/trf.13948. Epub 2016 Dec 20.

PMID:
28000304
9.

Clinical Evaluation of Proclination of Lower Anterior Teeth during Alignment using a Single Width Bracket-A Pilot Study.

Krishna NK, Farhan A, Issar R, Subramanian S, Muniyappa MP, Ranjan S, Singh P, Singh KT.

J Clin Diagn Res. 2016 Jun;10(6):ZC113-5. doi: 10.7860/JCDR/2016/19764.8066. Epub 2016 Jun 1.

10.

Comparative Evaluation of the Etching Pattern of Er,Cr:YSGG & Acid Etching on Extracted Human Teeth-An ESEM Analysis.

Issar R, Mazumdar D, Ranjan S, Krishna NK, Kole R, Singh P, Lakiang D, Jayam C.

J Clin Diagn Res. 2016 May;10(5):ZC01-5. doi: 10.7860/JCDR/2016/19739.7705. Epub 2016 May 1.

11.

Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.

Kumar PS, Pallera HK, Hair PS, Rivera MG, Shah TA, Werner AL, Lattanzio FA, Cunnion KM, Krishna NK.

Transfusion. 2016 Aug;56(8):2133-45. doi: 10.1111/trf.13674. Epub 2016 Jun 10.

PMID:
27282513
12.

Eosinophil Quantitated Urine Kinetic: A novel assay for assessment of eosinophilic esophagitis.

Cunnion KM, Willis LK, Minto HB, Burch TC, Werner AL, Shah TA, Krishna NK, Nyalwidhe JO, Maples KM.

Ann Allergy Asthma Immunol. 2016 May;116(5):435-9. doi: 10.1016/j.anai.2016.02.011. Epub 2016 Mar 24.

PMID:
27017558
13.

Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.

Cunnion KM, Hair PS, Krishna NK, Whitley PH, Goldberg CL, Fadeyi EA, Maes LY.

Transfusion. 2016 Jul;56(7):1845-8. doi: 10.1111/trf.13592. Epub 2016 Mar 20.

PMID:
26997226
14.

Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease.

Sass LA, Hair PS, Perkins AM, Shah TA, Krishna NK, Cunnion KM.

PLoS One. 2015 Dec 7;10(12):e0144723. doi: 10.1371/journal.pone.0144723. eCollection 2015.

15.

Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.

Sharp JA, Hair PS, Pallera HK, Kumar PS, Mauriello CT, Nyalwidhe JO, Phelps CA, Park D, Thielens NM, Pascal SM, Chen W, Duffy DM, Lattanzio FA, Cunnion KM, Krishna NK.

PLoS One. 2015 Jul 21;10(7):e0132446. doi: 10.1371/journal.pone.0132446. eCollection 2015.

16.

Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.

Mauriello CT, Hair PS, Rohn RD, Rister NS, Krishna NK, Cunnion KM.

J Diabetes Res. 2014;2014:762051. doi: 10.1155/2014/762051. Epub 2014 Dec 31.

17.

Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.

Sharp JA, Whitley PH, Cunnion KM, Krishna NK.

Front Immunol. 2014 Aug 22;5:406. doi: 10.3389/fimmu.2014.00406. eCollection 2014. Review.

18.

Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.

Shah TA, Mauriello CT, Hair PS, Sandhu A, Stolz MP, Bass WT, Krishna NK, Cunnion KM.

J Transl Med. 2014 Jun 24;12:181. doi: 10.1186/1479-5876-12-181.

19.

Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.

Shah TA, Mauriello CT, Hair PS, Sharp JA, Kumar PS, Lattanzio FA, Werner AL, Whitley PH, Maes LA, Cunnion KM, Krishna NK.

Transfusion. 2014 Nov;54(11):2892-900. doi: 10.1111/trf.12695. Epub 2014 May 8.

PMID:
24806146
20.

C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.

Douradinha B, McBurney SP, Soares de Melo KM, Smith AP, Krishna NK, Barratt-Boyes SM, Evans JD, Nascimento EJ, Marques ET Jr.

Virus Res. 2014 Jan 22;179:231-4. doi: 10.1016/j.virusres.2013.11.007. Epub 2013 Nov 15.

21.

Evolutionary dynamics of bovine coronaviruses: natural selection pattern of the spike gene implies adaptive evolution of the strains.

Bidokhti MR, Tråvén M, Krishna NK, Munir M, Belák S, Alenius S, Cortey M.

J Gen Virol. 2013 Sep;94(Pt 9):2036-49. doi: 10.1099/vir.0.054940-0. Epub 2013 Jun 26.

PMID:
23804565
22.

Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men.

Meites E, Krishna NK, Markowitz LE, Oster AM.

Sex Transm Dis. 2013 Feb;40(2):154-7. doi: 10.1097/OLQ.0b013e31827b9e89.

23.

Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.

Hair PS, Foley CK, Krishna NK, Nyalwidhe JO, Geoghegan JA, Foster TJ, Cunnion KM.

Results Immunol. 2013 Nov 9;3:114-21. doi: 10.1016/j.rinim.2013.10.004. eCollection 2013.

24.

Role of molecular diagnostics in the management of infectious disease emergencies.

Krishna NK, Cunnion KM.

Med Clin North Am. 2012 Nov;96(6):1067-78. doi: 10.1016/j.mcna.2012.08.005. Epub 2012 Sep 27. Review.

PMID:
23102477
25.

A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.

Mauriello CT, Pallera HK, Sharp JA, Woltmann JL Jr, Qian S, Hair PS, van der Pol P, van Kooten C, Thielens NM, Lattanzio FA, Cunnion KM, Krishna NK.

Mol Immunol. 2013 Jan;53(1-2):132-9. doi: 10.1016/j.molimm.2012.07.012. Epub 2012 Aug 18.

26.

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.

Hair PS, Echague CG, Rohn RD, Krishna NK, Nyalwidhe JO, Cunnion KM.

J Transl Med. 2012 Mar 5;10:35. doi: 10.1186/1479-5876-10-35.

27.

Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.

Gronemus JQ, Hair PS, Crawford KB, Nyalwidhe JO, Cunnion KM, Krishna NK.

Mol Immunol. 2010 Nov-Dec;48(1-3):305-13. doi: 10.1016/j.molimm.2010.07.012. Epub 2010 Aug 21.

PMID:
20728940
28.

Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.

Hair PS, Gronemus JQ, Crawford KB, Salvi VP, Cunnion KM, Thielens NM, Arlaud GJ, Rawal N, Krishna NK.

Mol Immunol. 2010 Jan;47(4):792-8. doi: 10.1016/j.molimm.2009.10.006. Epub 2009 Nov 6.

PMID:
19896716
29.

Human astrovirus coat protein: a novel C1 inhibitor.

Krishna NK, Cunnion KM.

Adv Exp Med Biol. 2008;632:237-51. Review.

PMID:
19025126
30.

Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.

Bonaparte RS, Hair PS, Banthia D, Marshall DM, Cunnion KM, Krishna NK.

J Virol. 2008 Jan;82(2):817-27. Epub 2007 Oct 24.

32.
33.

Complex formation among murine cytomegalovirus US22 proteins encoded by genes M139, M140, and M141.

Karabekian Z, Hanson LK, Slater JS, Krishna NK, Bolin LL, Kerry JA, Campbell AE.

J Virol. 2005 Mar;79(6):3525-35.

34.
35.
36.

Virus-like particles of a fish nodavirus display a capsid subunit domain organization different from that of insect nodaviruses.

Tang L, Lin CS, Krishna NK, Yeager M, Schneemann A, Johnson JE.

J Virol. 2002 Jun;76(12):6370-5.

37.

Characterization of virus-like particles assembled in a recombinant baculovirus system expressing the capsid protein of a fish nodavirus.

Lin CS, Lu MW, Tang L, Liu W, Chao CB, Lin CJ, Krishna NK, Johnson JE, Schneemann A.

Virology. 2001 Nov 10;290(1):50-8.

38.
39.

Formation of an RNA heterodimer upon heating of nodavirus particles.

Krishna NK, Schneemann A.

J Virol. 1999 Feb;73(2):1699-703.

40.

Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.

Bowzard JB, Bennett RP, Krishna NK, Ernst SM, Rein A, Wills JW.

J Virol. 1998 Nov;72(11):9034-44.

41.

Genetic determinants of Rous sarcoma virus particle size.

Krishna NK, Campbell S, Vogt VM, Wills JW.

J Virol. 1998 Jan;72(1):564-77.

42.

Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

Xiang Y, Ridky TW, Krishna NK, Leis J.

J Virol. 1997 Mar;71(3):2083-91.

43.
44.

Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

Pepinsky RB, Papayannopoulos IA, Chow EP, Krishna NK, Craven RC, Vogt VM.

J Virol. 1995 Oct;69(10):6430-8.

45.

Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.

Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW.

J Virol. 1995 Sep;69(9):5455-60.

Supplemental Content

Loading ...
Support Center